Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAC Study: peginterferon alfa-2a plus adefovir vs adefovir alone in HBeAg-negative chronic hepatitis B
2007-005332-83Phase 3Terminated
- Sponsor
- Azienda Ospedaliera di Caserta
- Start
- Sep 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of adefovir dipivoxil, peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Azienda Ospedaliera di Caserta. Started Sep 2008; status: terminated.
02
Drugs
adefovir dipivoxilpeginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2007-005332-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005332-83.